Antenatal description of large 4q13.2q21.23 deletion and outcomes

Abstract Background 4q21 microdeletion syndrome is an emergent non‐recurrent genomic disorder characterized by facial dysmorphy, progressive growth retardation, severe intellectual deficit, and absent or severely delayed speech. Deletions occur in clusters along 4q interstitial or terminal regions....

Full description

Bibliographic Details
Main Authors: Anna‐Gaëlle Giguet‐Valard, Christelle Thevenin, Sophie Dreux, Valérie Decatrelle, Marie‐Laure Juve, Soraya Yazza, Clara Adenet, Marion Lesueur, Patrice Bouvagnet, Michèle Gueneret
Format: Article
Language:English
Published: Wiley 2024-02-01
Series:Molecular Genetics & Genomic Medicine
Subjects:
Online Access:https://doi.org/10.1002/mgg3.2397
_version_ 1827341006040727552
author Anna‐Gaëlle Giguet‐Valard
Christelle Thevenin
Sophie Dreux
Valérie Decatrelle
Marie‐Laure Juve
Soraya Yazza
Clara Adenet
Marion Lesueur
Patrice Bouvagnet
Michèle Gueneret
author_facet Anna‐Gaëlle Giguet‐Valard
Christelle Thevenin
Sophie Dreux
Valérie Decatrelle
Marie‐Laure Juve
Soraya Yazza
Clara Adenet
Marion Lesueur
Patrice Bouvagnet
Michèle Gueneret
author_sort Anna‐Gaëlle Giguet‐Valard
collection DOAJ
description Abstract Background 4q21 microdeletion syndrome is an emergent non‐recurrent genomic disorder characterized by facial dysmorphy, progressive growth retardation, severe intellectual deficit, and absent or severely delayed speech. Deletions occur in clusters along 4q interstitial or terminal regions. 4q chromosomal aberrations are variable in type, size, and breakpoint. Genotype–phenotype correlation is a challenging task. The recurrent antenatal feature associated a posteriori with this syndrome is intrauterine growth retardation. There are very few precise antenatal descriptions of this syndrome. Methods We report here the first antenatal history of one of the largest deletion of this region. Results Our case harbored a 16.9 Mb deletion encompassing 135 protein coding genes including 20 OMIM morbid genes involved in neurological and cognitive abilities. Those breakpoints overlap two clusters of described microdeletion syndromes of cytogenetic band 4q13 and 4q21. Conclusion From the end of the second trimester, set of call signs associated with this syndrome can be completed by: excess of amniotic fluid, mild growth retardation, short long bones, bony anomalies of the extremities, and bulging cheeks. So, emphasis should be placed on the examination of the extremities, and the face during the routine targeted prenatal ultrasound.
first_indexed 2024-03-07T21:32:44Z
format Article
id doaj.art-6704bc2b360d4526a5cfba13553c780b
institution Directory Open Access Journal
issn 2324-9269
language English
last_indexed 2024-03-07T21:32:44Z
publishDate 2024-02-01
publisher Wiley
record_format Article
series Molecular Genetics & Genomic Medicine
spelling doaj.art-6704bc2b360d4526a5cfba13553c780b2024-02-26T14:52:29ZengWileyMolecular Genetics & Genomic Medicine2324-92692024-02-01122n/an/a10.1002/mgg3.2397Antenatal description of large 4q13.2q21.23 deletion and outcomesAnna‐Gaëlle Giguet‐Valard0Christelle Thevenin1Sophie Dreux2Valérie Decatrelle3Marie‐Laure Juve4Soraya Yazza5Clara Adenet6Marion Lesueur7Patrice Bouvagnet8Michèle Gueneret9Multidisciplinary Department for Antenatal Diagnosis/Rare Neurological and Neuromuscular Disorders University Hospital Center of Martinique Fort‐de‐France FrancePrivate Laboratory for Biological Tests – BIOLAB Martinique Fort‐de‐France FrancePre‐Natal Biochemistry Unit, Biochemistry‐Hormonology Laboratory Robert Debré Hospital, DMU Biogem AP‐HP Paris FranceMultidisciplinary Department for Antenatal Diagnosis/Rare Neurological and Neuromuscular Disorders University Hospital Center of Martinique Fort‐de‐France FranceMultidisciplinary Department for Antenatal Diagnosis/Rare Neurological and Neuromuscular Disorders University Hospital Center of Martinique Fort‐de‐France FranceMultidisciplinary Department for Antenatal Diagnosis/Rare Neurological and Neuromuscular Disorders University Hospital Center of Martinique Fort‐de‐France FranceRadiology Department University Hospital Center of Martinique Fort‐de‐France FranceGenomic Laboratory University Hospital of Necker Paris FranceMultidisciplinary Department for Antenatal Diagnosis/Rare Neurological and Neuromuscular Disorders University Hospital Center of Martinique Fort‐de‐France FranceMultidisciplinary Department for Antenatal Diagnosis/Rare Neurological and Neuromuscular Disorders University Hospital Center of Martinique Fort‐de‐France FranceAbstract Background 4q21 microdeletion syndrome is an emergent non‐recurrent genomic disorder characterized by facial dysmorphy, progressive growth retardation, severe intellectual deficit, and absent or severely delayed speech. Deletions occur in clusters along 4q interstitial or terminal regions. 4q chromosomal aberrations are variable in type, size, and breakpoint. Genotype–phenotype correlation is a challenging task. The recurrent antenatal feature associated a posteriori with this syndrome is intrauterine growth retardation. There are very few precise antenatal descriptions of this syndrome. Methods We report here the first antenatal history of one of the largest deletion of this region. Results Our case harbored a 16.9 Mb deletion encompassing 135 protein coding genes including 20 OMIM morbid genes involved in neurological and cognitive abilities. Those breakpoints overlap two clusters of described microdeletion syndromes of cytogenetic band 4q13 and 4q21. Conclusion From the end of the second trimester, set of call signs associated with this syndrome can be completed by: excess of amniotic fluid, mild growth retardation, short long bones, bony anomalies of the extremities, and bulging cheeks. So, emphasis should be placed on the examination of the extremities, and the face during the routine targeted prenatal ultrasound.https://doi.org/10.1002/mgg3.23974q21 microdeletion syndromeantenatal descriptionbony anomalies of the extremitiesexcess of amniotic fluidfull cheeksshort long bones
spellingShingle Anna‐Gaëlle Giguet‐Valard
Christelle Thevenin
Sophie Dreux
Valérie Decatrelle
Marie‐Laure Juve
Soraya Yazza
Clara Adenet
Marion Lesueur
Patrice Bouvagnet
Michèle Gueneret
Antenatal description of large 4q13.2q21.23 deletion and outcomes
Molecular Genetics & Genomic Medicine
4q21 microdeletion syndrome
antenatal description
bony anomalies of the extremities
excess of amniotic fluid
full cheeks
short long bones
title Antenatal description of large 4q13.2q21.23 deletion and outcomes
title_full Antenatal description of large 4q13.2q21.23 deletion and outcomes
title_fullStr Antenatal description of large 4q13.2q21.23 deletion and outcomes
title_full_unstemmed Antenatal description of large 4q13.2q21.23 deletion and outcomes
title_short Antenatal description of large 4q13.2q21.23 deletion and outcomes
title_sort antenatal description of large 4q13 2q21 23 deletion and outcomes
topic 4q21 microdeletion syndrome
antenatal description
bony anomalies of the extremities
excess of amniotic fluid
full cheeks
short long bones
url https://doi.org/10.1002/mgg3.2397
work_keys_str_mv AT annagaellegiguetvalard antenataldescriptionoflarge4q132q2123deletionandoutcomes
AT christellethevenin antenataldescriptionoflarge4q132q2123deletionandoutcomes
AT sophiedreux antenataldescriptionoflarge4q132q2123deletionandoutcomes
AT valeriedecatrelle antenataldescriptionoflarge4q132q2123deletionandoutcomes
AT marielaurejuve antenataldescriptionoflarge4q132q2123deletionandoutcomes
AT sorayayazza antenataldescriptionoflarge4q132q2123deletionandoutcomes
AT claraadenet antenataldescriptionoflarge4q132q2123deletionandoutcomes
AT marionlesueur antenataldescriptionoflarge4q132q2123deletionandoutcomes
AT patricebouvagnet antenataldescriptionoflarge4q132q2123deletionandoutcomes
AT michelegueneret antenataldescriptionoflarge4q132q2123deletionandoutcomes